Journal Report

MABS

Download PDF
Journal Information
Journal Title
MABS
Publisher
TAYLOR & FRANCIS INC
ISSN
1942-0862
E-ISSN
1942-0870
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Catching enhanced flexibility in antibody-antigen recognition: critical evaluation of physics-based and AI-driven methods
Honglin Xu, Ruyue Mi, Ganggang Bai et al.
2026-10-10 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2743404
Tangential flow filtration as a novel approach for fluorescent tracer purification and production up-scaling: cetuximab-800CW and ustekinumab-800CW as a proof-of-concept
Henrik K. Huizinga, Rosalie J. van Dijken, Bahez Gareb et al.
2026-10-8 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2743444
Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys
Kelsie Marks, Nirav Shah, Ly Pham et al.
2026-10-3 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2743413
NanoSaurus: addressing the urgent need for open access in single-domain antibody research
P. Di Filippo, E. Pardon, R.J. Owens et al.
2026-9-28 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2733370
Near pan-alphavirus neutralization by an antibody-nanobody bispecific
Sergei Pletnev, Christina L. Gardner, Matthew S. Sutton et al.
2026-9-23 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2731281
Predicting non-specific binding of VHHs using machine learning models with cluster-aware validation
Valentin Stanev, Federico Devalle, Mehdi Boroumand et al.
2026-9-16 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2732787
A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload
Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra et al.
2026-9-15 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2732607
Discovery and engineering of bispecific TCR-mimic antibodies targeting peptide–HLA complex
Jennifer Watkins-Yoon, Wei-Cheng Lu, Elyse M. Petrunak et al.
2026-9-12 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2731282
Correction
2026-9-12 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2728528
Preclinical development of ABL206, a novel bispecific antibody-drug conjugate targeting B7-H3 and ROR1
Jung A. Kwon, Suyoun Lee, Juhee Kim et al.
2026-9-12 Vol. 18 Issue 1
DOI: 10.1080/19420862.2026.2731283
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 28, 2026 08:48